carcinoembryonic antigen peptide 1
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 1998 (NCT00003434)
Timeline
Indications
Mechanism of action
- Carcinoembryonic antigen-related cell adhesion molecule 5Immunity, active
CEACAM5 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carcinoembryonic antigen peptide 1
- carcinoembryonic antigen peptide 1-6d
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00012246 | Phase 2 | Jul 1, 2002 | National Cancer Institute (NCI), The University of Texas, Dallas, University of Texas, Galveston |
| NCT00003434 | Phase 1 | Jun 1, 1998 | Duke University, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 2 | 1998 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 1998 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2002 |
| University of Texas, Galveston | Academic/Hospital | 1 | 1 | 1 | 2002 |
4 organizations
Page 1 / 1